Cyclopentenone prostaglandins (cyPG) are reactive lipidic mediators that are generated by dehydration of their parent PG.
The LOX and CYP assay is designed to monitor lipid mediators that are generated from the metabolism of LA, AA, EPA, and DHA by LOX or CYP enzymes.
The COX assay is designed to monitor lipid mediators that are generated from COX metabolism of DGLA, AA, and EPA and their 15-keto- and 13,14-dihydro-15-keto metabolites.
However, by inhibition of COX activity, these drugs are likely not only to affect PGE2 production but also to interfere with the production of mediators with differential effects that are generated by the same enzymatic pathways.
During the inflammatory process, large amounts of the pro-inflammatory mediators NO and prostaglandin E2 (PGE2) are generated by the inducible isoforms of NO synthase (NOS) and cyclooxygenase-2 (COX-2) [ 8].
In a separate experiment, Rayleigh waves are generated by the mediator technique.
Moreover, a number of recent studies support the view that sphingosine 1-phosphate (S1P), another powerful sphingoid mediator that can be generated by further metabolism of ceramide, exerts a critical role in myogenesis.
In the case of released arachidonic acid, a vast array of eicosanoids can be generated as mediators of neuroinflammation, a common feature of AD brain [ 38].
Unlike indirect electron transport involving mediator dispersion, an electron that is generated in the cell directly moves to the solid surface of the electrode through the outer membrane cytochromes [5, 6, 7, 8, 9, 10, 11, 12, 13, 14].
The influence of mediators such as cytokines that might be generated during HILP and their possible effects in systemic circulation have not been quantified.
